References (Section 5)

References for Dealing with uncertainty about the effects of treatments.

1 Cabello JB, Burls A. Emparanza JI, et al. Oxygen therapy for acute myocardial infarction. Cochrane Database of Systematic Reviews 2010, Issue 6. Art No.: CD007160.

2 Glasziou P, Chalmers I, Rawlins M, et al. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007:334:349-51.

3 Goh CL. Flashlamp-pumped pulsed dye laser (585nm) for the treatment of portwine stains: a study of treatment outcome in 94 Asian patients in Singapore. Singapore Medical Journal 2000;41:24-28.

4 Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New England Journal of Medicine 2001;344:1031-7.

5 Goldman J for the British Committee for Standards in Haematology. Recommendations for the management of BCR-ABL-positive chronic myeloid leukaemia. London: BSH, 2007.

6 Purohit N, Ray S, Wilson T, et al. The parent’s kiss: an effective way to remove paediatric nasal foreign bodies. Annals of the Royal College of Surgeons of England 2008:90:420-2.

7 Sanghavi DM. How should we tell the stories of our medical miracles? Lancet 2010;375:2068-9.

8 Léauté-Labrèze C, Dumas la Roque E, Hubische T, et al. Propranolol for severe hemangiomas of infancy. New England Journal of Medicine 2008;358:2649-51.

9 Huikeshoven M, Koster PHL, de Borgie CAJM, et al. Re-darkening of portwine stains 10 years after pulsed-dye-laser treatment. New England Journal of Medicine 2007;356:1235-40.

10 Waner M. Recent developments in lasers and the treatment of birthmarks. Archives of Disease in Childhood 2003;88:372-4.

11 Anti-Thrombotic Trialists’ (ATT) Collaboration. Clinical Trial Service Unit website.

12 Lin CWC, Moseley AM, Refshauge KM. Rehabilitation for ankle fractures in adults. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD005595.

13 Lindley RI. Personal communication, 2005.

14 Wardlaw JM, Murray V, Berge E, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD000213.

15 Schmidt B, Roberts RS, Davis P, et al; for the Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. New England Journal of Medicine 2007;357:1893-902.

16 Caffeine citrate (Comment) in Neonatal Formulary 5.

17 Kenyon S, Pike, K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008;372:1310-18.

18 Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008;372:1319-27.

19 Erythromycin (Comment) in: Neonatal Formulary 5.

20 Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569-75.

21 General Medical Council. Good Medical Practice. London: GMC, 2006, p13.

22 Ashcroft R. Giving medicine a fair trial. BMJ 2000;320:1686.

23 Pritchard-Jones K, Dixon-Woods M, Naafs-Wilstra M, et al. Improving recruitment to clinical trials for cancer in childhood. Lancet Oncology 2008;9:392-9.

24 Equator network resource centre for good reporting of health research studies.  Accessed 17th January 2012.

25 Smithells RW. Iatrogenic hazards and their effects. Postgraduate Medical Journal 1975;15:39-52.

Next Chapter: Fair tests of treatments